The National Breast Cancer Coalition (NBCC) is a grassroots network of tens of thousands of individuals and hundreds of groups that work to make breast cancer a priority for our government and for our nation. From the Coalition’s beginning, NBCC knew that breast cancer advocates needed a seat at the table where decisions are made that affect breast cancer public policy, research and funding. Once advocates were involved at the decision-making level, real change to the systems that affect breast cancer could be achieved to work toward the end goal of eradicating this disease.
In 1992, NBCC held its first Annual Advocacy Training Conference, which grew out of the need to educate and train advocates in all areas related to breast cancer, from research design and funding, to treatment, clinical trials and public policy. Conferences were held each year since then to bring advocates from all over the world to the Washington, DC area for three days of rigorous training that teaches advocates how to have a meaningful voice when it comes to breast cancer issues.
In 2010 the National Breast Cancer Coalition declared a deadline for the end of breast cancer - Breast Cancer Deadline 2020®. By bringing together unprecedented collaborations among scientists, visionaries, and advocates to catlyze, plan and implement work in the prevention of metastasis and the prevention of breast cancer development, NBCC plans to strategically reach the end of breast cancer by January 1, 2020.
Now in its 20th year, the conference is changing to reflect the high stakes of the Breast Cancer Deadline 2020® initiative. In 2012 the National Breast Cancer Coalition brings you the newly named Annual Advocate Summit. Attendees will learn that they can have a voice in determining research priorities and the direction of public policy and work side-by-side with scientists and policymakers as decision-making peers working on the end of breast cancer.
Get trained and feel empowered to have a significant role in Breast Cancer Deadline 2020®--the end of breast cancer by January 1, 2020.